NCT04868890View on ClinicalTrials.gov

A Study of Inhaled Ampion in Adults With Respiratory Distress Due to COVID-19

PHASE2TerminatedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

June 22, 2021

Primary Completion Date

February 16, 2022

Study Completion Date

April 13, 2022

Conditions
Covid19
Interventions
BIOLOGICAL

Ampion

Inhaled Ampion

OTHER

Placebo

Inhaled Placebo

Trial Locations (1)

80112

Ampio Pharmaceuticals, Englewood

Sponsors
All Listed Sponsors
lead

Ampio Pharmaceuticals. Inc.

INDUSTRY

NCT04868890 - A Study of Inhaled Ampion in Adults With Respiratory Distress Due to COVID-19 | Biotech Hunter | Biotech Hunter